Nifty

:

23587.50

Sensex

:

78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Login

Nifty
Sensex

:
:

23587.50
78041.59

-364.20 (-1.52%)
-1176.46 (-1.49%)

Ajanta Pharma Ltd.

Pharmaceuticals & Drugs - Global

Rating :

N/A

BSE: 532331 | NSE: AJANTPHARM

Watchlist

NSE BSE

2866.45

20-Dec-2024

Open
High
Low
Previous Close

2875.70
2907.05
2805.80
2875.70

Volume
Traded Value (lacs)
52 Week High
52 Week Low

111562
3210.43
3485.00
1952.00

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

35,621.18
40.71
2

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

35,558.67
1.79%
9.69

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

10 Years
5 Years
3 Years

11.07
10.22
8.00

EBITDA CAGR (%)

10 Years
5 Years
3 Years

8.78
11.39
4.75

PAT CAGR (%)

10 Years
5 Years
3 Years

10.17
11.78
4.62

P:E (Median)

8 Years
5 Years
3 Years

25.75
27.25
30.65

P:BV (Average)

8 Years
5 Years
3 Years

5.84
5.89
6.37

EV:EBITDA (Average)

8 Years
5 Years
3 Years

17.90
18.88
20.44

Earnings Forecasts:

Description 2024 2025 2026 2027
Adj EPS 64.82 76.41 88.37 109.78
P/E Ratio 46.7 39.61 34.25 27.57
Revenue 4162 4692 5267 5864
EBITDA 1172 1343 1550 1894
Net Income 816 962 1116 1386
ROA 17.5 20.4 20.4 19.5
P/Bk Ratio 10.75 9.53 8.04 6.32
ROE 23.47 25.27 25.39 25.71
FCFF 656.13 814.94 853.33 1339.72
FCFF Yield 1.77 2.2 2.31 3.62

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 1,128.91 945.18 19.44% 1,077.27 1,014.58 6.18% 926.07 848.86 9.10% 1,085.29 874.89 24.05%
Expenses 826.00 671.53 23.00% 761.44 737.68 3.22% 698.92 704.33 -0.77% 758.11 715.48 5.96%
EBITDA 302.91 273.65 10.69% 315.83 276.90 14.06% 227.15 144.53 57.16% 327.18 159.41 105.24%
EBIDTM 26.83% 28.95% 29.32% 27.29% 24.53% 17.03% 30.15% 18.22%
Other Income 40.34 52.16 -22.66% 28.37 31.46 -9.82% 33.68 36.75 -8.35% 13.73 30.51 -55.00%
Interest 0.73 2.27 -67.84% 0.72 0.75 -4.00% 1.42 1.21 17.36% 2.36 2.68 -11.94%
Depreciation 33.32 33.04 0.85% 32.92 32.24 2.11% 33.47 32.11 4.24% 33.41 32.29 3.47%
PBT 309.20 290.50 6.44% 310.56 275.37 12.78% 225.94 147.96 52.70% 305.14 154.95 96.93%
Tax 74.22 78.14 -5.02% 74.53 63.33 17.69% 63.25 30.75 105.69% 84.99 30.99 174.25%
PAT 234.98 212.36 10.65% 236.03 212.04 11.31% 162.69 117.21 38.80% 220.15 123.96 77.60%
PATM 20.81% 22.47% 21.91% 20.90% 17.57% 13.81% 20.28% 14.17%
EPS 18.81 17.00 10.65% 18.90 16.98 11.31% 13.03 9.38 38.91% 17.63 9.92 77.72%

Description Sep 24 Sep 23 Var% Jun 24 Jun 23 Var% Mar 24 Mar 23 Var% Dec 23 Dec 22 Var%
Net Sales 1,186.64 1,028.44 15.38% 1,144.92 1,021.04 12.13% 1,054.08 881.84 19.53% 1,105.15 971.77 13.73%
Expenses 875.47 737.78 18.66% 814.57 749.72 8.65% 775.76 732.47 5.91% 791.08 802.22 -1.39%
EBITDA 311.17 290.66 7.06% 330.35 271.32 21.76% 278.32 149.37 86.33% 314.07 169.55 85.24%
EBIDTM 26.22% 28.26% 28.85% 26.57% 26.40% 16.94% 28.42% 17.45%
Other Income 19.48 21.33 -8.67% 26.47 31.75 -16.63% 35.50 36.83 -3.61% 13.59 34.93 -61.09%
Interest 6.02 2.34 157.26% 0.73 0.85 -14.12% 1.53 1.13 35.40% 2.49 2.84 -12.32%
Depreciation 34.39 33.71 2.02% 33.97 33.18 2.38% 34.25 33.02 3.73% 34.26 33.30 2.88%
PBT 290.24 275.94 5.18% 322.12 269.04 19.73% 278.04 152.05 82.86% 290.91 168.34 72.81%
Tax 73.76 80.64 -8.53% 76.35 60.92 25.33% 75.32 29.80 152.75% 80.88 33.83 139.08%
PAT 216.48 195.30 10.84% 245.77 208.12 18.09% 202.72 122.25 65.82% 210.03 134.51 56.14%
PATM 18.24% 18.99% 21.47% 20.38% 19.23% 13.86% 19.00% 13.84%
EPS 17.27 15.46 11.71% 19.61 16.47 19.06% 16.04 9.68 65.70% 16.62 10.46 58.89%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,217.54 3,971.12 3,411.27 3,140.64 2,718.59 2,196.42 1,772.62 1,825.35 1,804.33 1,558.21 1,356.20 Net Sales Growth 14.50% 16.41% 8.62% 15.52% 23.77% 23.91% -2.89% 1.16% 15.80% 14.90% Cost Of Goods Sold 1,072.81 892.98 824.32 679.10 600.59 546.67 304.80 311.26 348.99 318.31 306.55 Gross Profit 3,144.73 3,078.14 2,586.95 2,461.54 2,118.00 1,649.75 1,467.82 1,514.09 1,455.34 1,239.90 1,049.65 GP Margin 74.56% 77.51% 75.84% 78.38% 77.91% 75.11% 82.81% 82.95% 80.66% 79.57% 77.40% Total Expenditure 3,044.47 2,851.69 2,711.99 2,249.75 1,801.68 1,663.64 1,291.41 1,278.54 1,169.91 1,035.65 883.64 Power & Fuel Cost - 66.44 65.53 54.09 43.42 38.56 33.77 27.00 18.36 15.15 12.58 % Of Sales - 1.67% 1.92% 1.72% 1.60% 1.76% 1.91% 1.48% 1.02% 0.97% 0.93% Employee Cost - 834.16 720.41 585.87 498.11 437.82 389.37 342.89 269.78 235.03 186.34 % Of Sales - 21.01% 21.12% 18.65% 18.32% 19.93% 21.97% 18.78% 14.95% 15.08% 13.74% Manufacturing Exp. - 303.25 320.69 273.91 225.39 203.80 176.40 212.44 188.68 173.18 129.58 % Of Sales - 7.64% 9.40% 8.72% 8.29% 9.28% 9.95% 11.64% 10.46% 11.11% 9.55% General & Admin Exp. - 362.85 348.78 289.42 123.71 150.92 165.95 122.50 85.96 61.61 46.98 % Of Sales - 9.14% 10.22% 9.22% 4.55% 6.87% 9.36% 6.71% 4.76% 3.95% 3.46% Selling & Distn. Exp. - 313.06 354.87 316.58 248.70 225.44 178.54 173.75 161.51 164.06 154.44 % Of Sales - 7.88% 10.40% 10.08% 9.15% 10.26% 10.07% 9.52% 8.95% 10.53% 11.39% Miscellaneous Exp. - 78.95 77.39 50.78 61.76 60.43 42.58 88.70 96.63 68.31 154.44 % Of Sales - 1.99% 2.27% 1.62% 2.27% 2.75% 2.40% 4.86% 5.36% 4.38% 3.48% EBITDA 1,173.07 1,119.43 699.28 890.89 916.91 532.78 481.21 546.81 634.42 522.56 472.56 EBITDA Margin 27.81% 28.19% 20.50% 28.37% 33.73% 24.26% 27.15% 29.96% 35.16% 33.54% 34.84% Other Income 116.12 116.48 132.75 139.73 103.57 184.20 102.15 73.01 66.95 86.87 33.70 Interest 5.23 6.80 5.23 9.12 6.90 9.10 0.41 0.24 1.24 4.19 5.01 Depreciation 133.12 132.16 126.95 120.96 111.49 91.29 69.90 57.14 59.48 42.68 49.42 PBT 1,150.84 1,096.95 699.85 900.54 902.09 616.59 513.05 562.44 640.65 562.56 451.83 Tax 296.99 289.71 141.13 180.68 226.45 171.54 121.29 134.92 140.84 140.61 138.51 Tax Rate 25.81% 26.41% 20.17% 20.06% 25.10% 28.00% 23.64% 23.99% 21.98% 24.99% 31.13% PAT 853.85 807.24 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 306.37 PAT before Minority Interest 853.85 807.24 558.72 719.86 675.64 441.13 391.76 427.52 499.81 421.95 306.37 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 20.25% 20.33% 16.38% 22.92% 24.85% 20.08% 22.10% 23.42% 27.70% 27.08% 22.59% PAT Growth 28.29% 44.48% -22.38% 6.54% 53.16% 12.60% -8.36% -14.46% 18.45% 37.73% EPS 68.36 64.63 44.73 57.63 54.09 35.32 31.37 34.23 40.02 33.78 24.53

Description TTM Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Net Sales 4,490.79 4,208.71 3,742.64 3,340.99 2,889.69 2,587.87 2,055.37 2,125.76 1,983.26 1,733.98 1,473.56 Net Sales Growth 15.06% 12.45% 12.02% 15.62% 11.66% 25.91% -3.31% 7.19% 14.38% 17.67% Cost Of Goods Sold 1,088.08 880.13 869.31 677.73 514.99 537.75 295.72 317.35 322.58 317.33 290.33 Gross Profit 3,402.71 3,328.58 2,873.33 2,663.26 2,374.70 2,050.12 1,759.65 1,808.41 1,660.68 1,416.65 1,183.23 GP Margin 75.77% 79.09% 76.77% 79.71% 82.18% 79.22% 85.61% 85.07% 83.73% 81.70% 80.30% Total Expenditure 3,256.88 3,036.77 2,959.39 2,411.70 1,891.13 1,904.55 1,488.94 1,467.37 1,296.38 1,146.92 968.33 Power & Fuel Cost - 66.57 65.71 54.38 43.70 38.88 32.65 27.42 18.70 15.49 12.91 % Of Sales - 1.58% 1.76% 1.63% 1.51% 1.50% 1.59% 1.29% 0.94% 0.89% 0.88% Employee Cost - 900.34 785.14 645.78 548.25 485.59 430.71 376.47 295.42 256.64 200.58 % Of Sales - 21.39% 20.98% 19.33% 18.97% 18.76% 20.96% 17.71% 14.90% 14.80% 13.61% Manufacturing Exp. - 303.29 320.81 275.42 226.20 204.81 174.78 215.80 192.70 174.40 130.81 % Of Sales - 7.21% 8.57% 8.24% 7.83% 7.91% 8.50% 10.15% 9.72% 10.06% 8.88% General & Admin Exp. - 382.26 365.86 300.83 131.64 159.49 149.90 131.92 92.02 66.24 50.99 % Of Sales - 9.08% 9.78% 9.00% 4.56% 6.16% 7.29% 6.21% 4.64% 3.82% 3.46% Selling & Distn. Exp. - 417.54 463.94 400.29 374.73 413.70 320.99 306.30 270.92 245.92 233.96 % Of Sales - 9.92% 12.40% 11.98% 12.97% 15.99% 15.62% 14.41% 13.66% 14.18% 15.88% Miscellaneous Exp. - 86.64 88.62 57.27 51.62 64.33 84.19 92.11 104.04 70.90 233.96 % Of Sales - 2.06% 2.37% 1.71% 1.79% 2.49% 4.10% 4.33% 5.25% 4.09% 3.31% EBITDA 1,233.91 1,171.94 783.25 929.29 998.56 683.32 566.43 658.39 686.88 587.06 505.23 EBITDA Margin 27.48% 27.85% 20.93% 27.81% 34.56% 26.40% 27.56% 30.97% 34.63% 33.86% 34.29% Other Income 95.04 84.60 98.64 115.68 25.98 92.19 21.08 24.16 23.86 21.15 16.80 Interest 10.77 7.21 5.84 10.20 8.27 11.91 1.16 0.41 1.36 4.89 5.92 Depreciation 136.87 135.40 130.80 125.29 116.09 95.71 72.08 59.59 61.21 44.43 51.64 PBT 1,181.31 1,113.93 745.25 909.48 900.18 667.89 514.27 622.55 648.17 558.89 464.47 Tax 306.31 297.76 157.27 196.80 246.31 196.27 127.30 153.91 141.34 143.28 146.15 Tax Rate 25.93% 26.73% 21.10% 21.64% 27.36% 29.56% 24.75% 24.72% 21.81% 25.64% 32.05% PAT 875.00 816.17 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 309.86 PAT before Minority Interest 875.00 816.17 587.98 712.68 653.87 467.70 386.97 468.64 506.83 415.61 309.86 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 19.48% 19.39% 15.71% 21.33% 22.63% 18.07% 18.83% 22.05% 25.56% 23.97% 21.03% PAT Growth 32.54% 38.81% -17.50% 8.99% 39.81% 20.86% -17.43% -7.54% 21.95% 34.13% EPS 70.06 65.35 47.08 57.06 52.35 37.45 30.98 37.52 40.58 33.28 24.81

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,413.57 3,246.45 3,169.18 2,884.98 2,461.30 2,142.08 1,931.50 1,503.94 1,131.70 786.33 Share Capital 25.27 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 17.68 Total Reserves 3,382.65 3,220.84 3,151.71 2,867.04 2,443.29 2,123.44 1,912.18 1,486.25 1,114.01 768.22 Non-Current Liabilities 174.17 272.90 338.33 321.18 252.27 193.38 60.16 32.36 40.44 54.69 Secured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 4.73 22.32 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.09 9.95 Long Term Provisions 39.54 146.55 216.04 208.12 155.01 134.15 13.16 4.89 2.59 4.76 Current Liabilities 629.19 907.84 469.70 706.28 614.30 427.47 300.19 212.24 241.55 244.83 Trade Payables 383.74 353.02 274.37 317.20 302.77 185.53 211.47 145.31 145.04 108.12 Other Current Liabilities 190.39 529.32 176.59 152.32 153.28 113.56 68.01 46.09 50.68 54.51 Short Term Borrowings 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 34.47 17.90 Short Term Provisions 55.06 25.50 18.74 236.76 158.25 128.38 20.71 20.84 11.36 64.30 Total Liabilities 4,216.93 4,427.19 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69 1,085.85 Net Block 1,464.89 1,484.01 1,483.91 1,518.79 1,449.32 1,152.14 1,036.69 572.93 432.83 271.32 Gross Block 2,355.33 2,246.28 2,152.24 2,086.53 1,926.64 1,540.50 1,379.38 859.28 679.21 510.92 Accumulated Depreciation 890.44 762.27 668.33 567.74 477.32 388.36 342.69 286.35 246.38 239.60 Non Current Assets 1,775.77 1,876.00 1,920.20 1,886.04 1,773.43 1,593.76 1,196.84 973.47 715.27 512.82 Capital Work in Progress 256.45 209.47 152.86 108.19 131.06 261.29 61.33 254.22 198.91 170.20 Non Current Investment 37.09 42.99 42.99 17.89 18.63 28.14 18.26 17.26 17.25 57.16 Long Term Loans & Adv. 12.97 134.68 226.15 230.52 163.96 139.91 66.38 34.93 21.12 8.87 Other Non Current Assets 4.37 4.85 5.88 10.65 10.46 12.28 14.18 9.09 4.27 5.27 Current Assets 2,432.82 2,543.27 2,057.01 2,026.40 1,554.44 1,169.17 1,095.01 775.07 698.42 573.03 Current Investments 330.05 510.27 121.86 138.99 67.14 64.74 182.38 181.56 76.78 19.46 Inventories 677.79 683.77 635.11 634.22 436.19 414.26 317.37 179.28 189.78 153.05 Sundry Debtors 1,207.67 977.63 1,043.62 782.30 734.24 423.38 432.19 336.00 350.48 240.85 Cash & Bank 63.06 269.92 145.25 151.98 87.85 35.87 38.67 22.84 21.44 105.69 Other Current Assets 154.25 18.56 29.78 99.10 229.02 230.92 124.40 55.39 59.94 53.98 Short Term Loans & Adv. 109.91 83.12 81.39 219.81 163.63 137.20 12.71 48.26 53.75 42.01 Net Current Assets 1,803.63 1,635.43 1,587.31 1,320.12 940.14 741.70 794.82 562.83 456.87 328.20 Total Assets 4,208.59 4,419.27 3,977.21 3,912.44 3,327.87 2,762.93 2,291.85 1,748.54 1,413.69 1,085.85

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Shareholder's Funds 3,567.36 3,387.99 3,264.34 2,995.63 2,598.87 2,245.21 2,041.37 1,567.69 1,190.86 841.09 Share Capital 25.27 25.27 17.17 17.39 17.54 17.54 17.69 17.69 17.69 17.68 Total Reserves 3,536.44 3,362.38 3,246.87 2,977.70 2,580.86 2,226.57 2,022.05 1,550.00 1,173.17 822.98 Non-Current Liabilities 40.82 177.38 285.02 274.55 227.61 162.23 38.56 8.90 28.63 55.67 Secured Loans 0.00 1.25 1.64 1.60 0.74 0.66 1.01 1.04 5.79 23.31 Unsecured Loans 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 9.08 9.94 Long Term Provisions 39.54 146.55 216.04 208.12 155.01 134.15 13.16 4.88 2.59 4.76 Current Liabilities 895.25 1,139.28 647.39 838.82 745.53 498.35 346.05 246.66 259.89 249.59 Trade Payables 463.20 422.77 327.17 373.86 362.34 225.18 249.63 178.18 145.57 109.06 Other Current Liabilities 369.52 669.42 301.47 214.14 180.12 111.45 63.95 46.33 56.72 58.33 Short Term Borrowings 0.00 0.00 0.00 0.00 42.85 33.34 0.00 0.00 46.25 17.90 Short Term Provisions 62.53 47.09 18.75 250.82 160.22 128.38 32.47 22.15 11.35 64.30 Total Liabilities 4,503.43 4,704.65 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38 1,146.35 Net Block 1,479.19 1,496.44 1,503.58 1,541.11 1,472.14 1,168.35 1,052.66 589.17 450.74 288.09 Gross Block 2,389.41 2,282.82 2,206.86 2,140.80 1,976.15 1,578.96 1,417.23 894.94 715.73 549.85 Accumulated Depreciation 910.22 786.38 703.28 599.69 504.01 410.61 364.57 305.77 264.99 261.76 Non Current Assets 1,773.02 1,870.65 1,932.29 1,891.22 1,790.94 1,605.27 1,202.36 972.65 716.11 512.94 Capital Work in Progress 256.45 209.47 152.86 108.19 131.86 261.61 61.33 254.22 198.91 170.20 Non Current Investment 18.58 25.10 25.10 0.00 12.28 22.87 7.58 0.00 0.00 40.04 Long Term Loans & Adv. 14.43 134.79 236.46 230.74 164.20 148.36 76.79 41.88 21.29 9.34 Other Non Current Assets 4.37 4.85 5.88 11.18 10.46 4.08 4.00 2.34 4.28 5.27 Current Assets 2,722.07 2,825.18 2,264.46 2,217.78 1,781.07 1,300.52 1,223.62 850.60 763.27 633.41 Current Investments 330.05 510.27 121.86 175.67 67.14 64.74 182.38 181.56 76.78 19.46 Inventories 828.36 815.63 791.07 766.47 495.68 435.71 350.63 211.02 204.58 159.03 Sundry Debtors 1,246.84 1,056.90 1,019.81 738.43 775.30 459.48 459.79 323.15 372.35 258.76 Cash & Bank 130.77 330.90 211.79 209.61 205.25 100.51 93.09 69.95 43.37 136.76 Other Current Assets 186.05 22.09 34.79 104.15 237.70 240.08 137.73 64.92 66.19 59.40 Short Term Loans & Adv. 132.29 89.39 85.14 223.45 168.68 143.45 23.11 56.29 59.39 47.43 Net Current Assets 1,826.82 1,685.90 1,617.07 1,378.96 1,035.54 802.17 877.57 603.94 503.38 383.82 Total Assets 4,495.09 4,695.83 4,196.75 4,109.00 3,572.01 2,905.79 2,425.98 1,823.25 1,479.38 1,146.35

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 735.35 736.29 542.34 466.99 300.88 311.82 219.17 536.90 276.67 262.92 PBT 1,096.95 699.85 900.54 902.09 612.67 513.05 562.44 640.65 562.56 444.88 Adjustment 49.31 79.34 55.58 37.07 -36.60 -11.56 0.21 40.16 -21.87 34.18 Changes in Working Capital -158.63 82.66 -220.31 -274.26 -136.66 -86.64 -221.02 -13.32 -111.94 -80.75 Cash after chg. in Working capital 987.63 861.85 735.81 664.90 439.41 414.85 341.63 667.49 428.75 398.31 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -252.28 -125.56 -193.47 -197.91 -138.53 -103.03 -122.46 -130.59 -152.08 -135.39 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 105.02 -501.31 -66.04 -162.68 -115.91 -136.88 -201.13 -339.66 -139.39 -145.63 Net Fixed Assets -156.03 -150.65 -110.38 -137.02 -255.91 -361.08 -327.21 -235.38 -197.00 -138.00 Net Investments 186.12 -388.41 -7.97 -71.11 7.11 107.76 -1.82 -104.79 -17.41 2.22 Others 74.93 37.75 52.31 45.45 132.89 116.44 127.90 0.51 75.02 -9.85 Cash from Financing Activity -1,047.70 -105.12 -457.30 -268.90 -134.00 -180.89 -0.54 -198.02 -128.38 -101.18 Net Cash Inflow / Outflow -207.33 129.86 19.00 35.41 50.97 -5.95 17.50 -0.78 8.90 16.11 Opening Cash & Equivalents 268.85 139.83 119.88 84.95 30.52 36.22 18.72 19.49 10.59 7.30 Closing Cash & Equivalent 61.52 269.69 138.88 120.36 81.49 30.27 36.22 18.71 19.49 23.41

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Cash From Operating Activity 785.07 792.11 561.71 576.31 456.77 374.51 281.12 609.29 326.14 279.42 PBT 1,113.93 745.25 909.48 900.18 663.97 514.27 622.56 648.17 558.90 456.01 Adjustment 83.03 131.30 91.75 115.27 70.79 61.93 52.48 86.33 53.07 51.21 Changes in Working Capital -99.76 66.85 -200.39 -208.75 -123.16 -83.46 -254.32 25.88 -124.34 -81.69 Cash after chg. in Working capital 1,097.20 943.40 800.84 806.70 611.60 492.74 420.72 760.38 487.63 425.53 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid -312.13 -151.29 -239.13 -230.39 -154.83 -118.23 -139.60 -151.09 -161.49 -146.11 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Cash From Investing Activity 65.39 -559.60 -74.10 -282.38 -224.40 -222.78 -256.11 -383.12 -209.07 -158.36 Net Fixed Assets -156.03 -150.65 -110.38 -137.02 -255.91 -361.08 -327.21 -235.38 -197.00 -138.00 Net Investments 186.12 -388.41 -7.97 -71.11 7.11 107.76 -1.82 -104.79 -17.41 2.22 Others 35.30 -20.54 44.25 -74.25 24.40 30.54 72.92 -42.95 5.34 -22.58 Cash from Financing Activity -1,051.06 -108.20 -459.71 -318.29 -128.63 -147.46 -0.20 -201.77 -117.32 -105.19 Net Cash Inflow / Outflow -200.60 124.31 27.90 -24.36 103.74 4.27 24.81 24.40 -0.25 15.87 Opening Cash & Equivalents 329.83 206.36 177.51 202.35 95.16 90.64 65.83 41.42 41.67 38.62 Closing Cash & Equivalent 129.23 330.67 205.41 177.99 198.90 94.91 90.64 65.82 41.42 54.49

Financial Ratios

Consolidated /

Standalone

Right to Left

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 270.68 257.83 247.37 222.30 282.03 245.37 219.29 170.89 128.59 89.35 ROA 18.68% 13.30% 18.25% 18.66% 14.49% 15.50% 21.16% 31.61% 33.76% 31.17% ROE 24.26% 17.42% 23.78% 25.28% 19.17% 19.25% 24.90% 37.93% 44.01% 46.37% ROCE 33.15% 21.98% 30.05% 34.00% 27.01% 25.21% 32.76% 47.50% 55.13% 59.10% Fixed Asset Turnover 1.78 1.59 1.50 1.37 1.27 1.21 1.64 2.37 2.64 2.85 Receivable days 97.40 105.33 104.55 100.41 96.19 88.09 76.59 68.73 68.58 55.76 Inventory Days 60.68 68.73 72.68 70.87 70.66 75.32 49.52 36.95 39.76 40.27 Payable days 150.57 138.90 158.98 188.39 57.84 60.10 55.05 50.18 46.47 47.80 Cash Conversion Cycle 7.51 35.15 18.26 -17.11 109.01 103.31 71.06 55.51 61.87 48.23 Total Debt/Equity 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.06 0.09 Interest Cover 162.32 134.81 99.74 131.74 68.33 1252.34 2344.50 517.65 135.26 89.80

Description Mar 24 Mar 23 Mar 22 Mar 21 Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15
Book Value (Rs.) 282.89 269.07 254.80 230.83 297.80 257.19 231.78 178.14 135.31 95.57 ROA 17.73% 13.21% 17.16% 17.03% 14.44% 14.52% 22.06% 30.69% 31.66% 29.57% ROE 23.49% 17.68% 22.77% 23.38% 19.32% 18.07% 25.98% 36.75% 40.92% 43.24% ROCE 32.22% 22.57% 29.37% 32.20% 27.44% 23.84% 34.49% 45.74% 51.61% 56.43% Fixed Asset Turnover 3.42 3.19 1.56 1.43 1.46 1.37 1.84 2.49 2.76 2.85 Receivable days 52.69 52.87 94.50 93.66 87.08 81.62 67.06 63.41 65.84 56.64 Inventory Days 37.60 40.91 83.71 78.09 65.68 69.82 48.10 37.89 37.93 38.64 Payable days 183.71 157.44 188.77 260.89 59.55 63.24 57.26 50.30 41.91 46.38 Cash Conversion Cycle -93.41 -63.66 -10.56 -89.14 93.21 88.21 57.90 51.01 61.86 48.91 Total Debt/Equity 0.00 0.00 0.00 0.00 0.02 0.02 0.00 0.00 0.07 0.09 Interest Cover 155.50 128.61 90.16 109.85 56.75 444.34 1519.41 477.60 115.29 78.03

Top Investors:

nippon life india trustee ltd-a/c nippon india small cap fund

uti flexi cap fund

hdfc large and mid cap fund

tata aia life insurance co ltd-whole life mid cap equity fund-ulif 009 04/01/07 wle 110

kotak small cap fund

aditya birla sun life trustee private limited a/c aditya birla sun life equity advantage fund

canara robeco mutual fund a/c canara robeco small cap fund

investor education and protection fund (iepf)

Annual Reports:

News Update:

Ajanta Pharma - Quarterly Results
28th Oct 2024, 15:51 PM

Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.

Feedback